GlassScriptPhysician profile
Kirk David Potter
NPI 1003920877
$749.60
in general payments reported to CMS, 2019-2025
14 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $39.99 · 2021: $336 · 2022: $16.61 · 2024: $94.58 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $320.78 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Biosense Webster, INC. | $102.37 | 2024-2025 | Carto 3 |
| Galderma Laboratories, L.P. | $79.80 | 2019-2021 | |
| Avita Medical Americas, LLC | $38.37 | 2024 | |
| Integra Lifesciences Corporation | $32.59 | 2021 | |
| Allergan, INC. | $30.46 | 2019-2021 | |
| Biowound Solutions, INC. | $25.66 | 2025 | Bio-Connekt |
| Abbvie INC. | $22.64 | 2025 | |
| Angiodynamics, INC. | $18.00 | 2021 | |
| Greer Laboratories, INC. | $17.58 | 2025 | Oralair |
| Genentech USA, INC. | $16.61 | 2022 | |
| Tei Medical INC. | $16.07 | 2019 | |
| Smith+Nephew, INC. | $15.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.